Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Hematologic Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 12 Lung Neoplasms 9 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Breast Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Smoking Cessation 1 Skin Neoplasms 1 Sezary Syndrome 1 Retroviridae Infections 1

Interventions

Cyclophosphamide 82 Etoposide 45 Carboplatin 38 Temozolomide 37 Filgrastim 37 Vincristine 36 Melphalan 36 Isotretinoin 36 Irinotecan 36 Topotecan 35 Doxorubicin 33 3-Iodobenzylguanidine 31 Granulocyte Colony-Stimulating Factor 26 Peripheral Blood Stem Cell Transplantation 25 Cisplatin 25 dinutuximab 22 sargramostim 21 Radiotherapy 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Busulfan 19 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡